Allan Mark Lefer
#96,472
Most Influential Person Now
Allan Mark Lefer's AcademicInfluence.com Rankings
Allan Mark Lefermedical Degrees
Medical
#1061
World Rank
#1356
Historical Rank
Cardiology
#62
World Rank
#63
Historical Rank
Pharmacology
#76
World Rank
#99
Historical Rank
Allan Mark Leferphilosophy Degrees
Philosophy
#3667
World Rank
#5881
Historical Rank
Logic
#1316
World Rank
#2036
Historical Rank
Download Badge
Medical Philosophy
Why Is Allan Mark Lefer Influential?
(Suggest an Edit or Addition)Allan Mark Lefer's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Diminished basal nitric oxide release after myocardial ischemia and reperfusion promotes neutrophil adherence to coronary endothelium. (1993) (532)
- Time course of endothelial dysfunction and myocardial injury during myocardial ischemia and reperfusion in the cat. (1990) (516)
- In vivo neutralization of P-selectin protects feline heart and endothelium in myocardial ischemia and reperfusion injury. (1993) (463)
- Cardioprotective effect of insulin-like growth factor I in myocardial ischemia followed by reperfusion. (1995) (415)
- The role of nitric oxide and cell adhesion molecules on the microcirculation in ischaemia-reperfusion. (1996) (405)
- Simvastatin preserves the ischemic-reperfused myocardium in normocholesterolemic rat hearts. (1999) (360)
- Role of endothelial dysfunction in the pathogenesis of reperfusion injury after myocardial ischemia (1991) (347)
- The Role of L‐Arginine in Ameliorating Reperfusion Injury After Myocardial Ischemia in the Cat (1992) (344)
- Pharmacology of the endothelium in ischemia-reperfusion and circulatory shock. (1993) (323)
- Antibody to CD-18 exerts endothelial and cardiac protective effects in myocardial ischemia and reperfusion. (1991) (316)
- Coronary Endothelial and Cardiac Protective Effects of a Monoclonal Antibody to Intercellular Adhesion Molecule‐1 in Myocardial Ischemia and Reperfusion (1992) (315)
- Mediation of cardioprotection by transforming growth factor-beta. (1990) (307)
- Inhibition of endothelial-derived nitric oxide promotes P-selectin expression and actions in the rat microcirculation. (1994) (304)
- Peroxynitrite inhibits leukocyte-endothelial cell interactions and protects against ischemia-reperfusion injury in rats. (1997) (281)
- Vascular effects of HMG CoA-reductase inhibitors (statins) unrelated to cholesterol lowering: new concepts for cardiovascular disease. (2001) (274)
- Nitric oxide attenuates leukocyte-endothelial interaction via P-selectin in splanchnic ischemia-reperfusion. (1994) (261)
- Monoclonal Antibody to L‐Selectin Attenuates Neutrophil Accumulation and Protects Ischemic Reperfused Cat Myocardium (1993) (256)
- Nitric oxide protects against leukocyte-endothelium interactions in the early stages of hypercholesterolemia. (1995) (256)
- Cardioprotection and attenuation of endothelial dysfunction by organic nitric oxide donors in myocardial ischemia-reperfusion. (1992) (254)
- Simvastatin inhibits leukocyte-endothelial cell interactions and protects against inflammatory processes in normocholesterolemic rats. (1999) (252)
- Thromboxane Release During Pacing-induced Angina Pectoris: Possible Vasoconstrictor Influence on the Coronary Vasculature (1980) (245)
- Prostacyclin: a potentially valuable agent for preserving myocardial tissue in acute myocardial ischemia. (1978) (242)
- Cardioprotective effects of authentic nitric oxide in myocardial ischemia with reperfusion (1991) (229)
- Time course and mechanism of endothelial dysfunction in isolated ischemic- and hypoxic-perfused rat hearts. (1990) (219)
- Cardioprotective effects of a C1 esterase inhibitor in myocardial ischemia and reperfusion. (1995) (213)
- Simvastatin Exerts Both Anti-inflammatory and Cardioprotective Effects in Apolipoprotein E—Deficient Mice (2001) (212)
- A new HMG‐CoA reductase inhibitor, rosuvastatin, exerts anti‐inflammatory effects on the microvascular endothelium: the role of mevalonic acid (2001) (209)
- Role of selectins, a new family of adhesion molecules, in ischaemia-reperfusion injury. (1994) (176)
- Synergism between platelets and neutrophils in provoking cardiac dysfunction after ischemia and reperfusion: role of selectins. (1998) (172)
- Cardiovascular effects of acute hypercholesterolemia in rabbits. Reversal with lovastatin treatment. (1989) (164)
- Sialyl Lewisx-containing oligosaccharide attenuates myocardial reperfusion injury in cats. (1994) (161)
- Studies on the protective effect of prostacyclin in acute myocardial ischemia. (1979) (157)
- Decreased basal nitric oxide release in hypercholesterolemia increases neutrophil adherence to rabbit coronary artery endothelium. (1993) (156)
- Lack of endothelium-dependent relaxation in coronary resistance arteries of cholesterol-fed rabbits. (1989) (153)
- Cytoprotective actions of prostacyclin during hypoxia in the isolated perfused cat liver. (1980) (153)
- Leukocyte-endothelium interaction during the early stages of hypercholesterolemia in the rabbit: role of P-selectin, ICAM-1, and VCAM-1. (1998) (146)
- Physiological concentrations of nitric oxide do not elicit an acute negative inotropic effect in unstimulated cardiac muscle. (1994) (146)
- Origin of myocardial depressant factor in shock. (1970) (139)
- Dissociation of vasoconstrictor and platelet aggregatory activities of thromboxane by carbocyclic thromboxane A2, a stable analog of thromboxane A2. (1980) (134)
- Recombinant soluble P-selectin glycoprotein ligand-1 protects against myocardial ischemic reperfusion injury in cats. (1999) (133)
- Lysophosphatidylcholine promotes P-selectin expression in platelets and endothelial cells. Possible involvement of protein kinase C activation and its inhibition by nitric oxide donors. (1996) (129)
- Anti-EDRF effect of tumor necrosis factor in isolated, perfused cat carotid arteries. (1989) (129)
- Lipoxin A4 stable analogs inhibit leukocyte rolling and adherence in the rat mesenteric microvasculature: role of P-selectin. (1997) (127)
- Role of a myocardial depressant factor in the pathogenesis of circulatory shock. (1970) (127)
- Mechanism of the cardioprotective effect of transforming growth factor beta 1 in feline myocardial ischemia and reperfusion. (1993) (124)
- Blockade of platelet endothelial cell adhesion molecule-1 protects against myocardial ischemia and reperfusion injury in cats. (1996) (119)
- Role of Prostacyclin in the Preservation of Ischemic Myocardial Tissue in the Perfused Cat Heart (1980) (118)
- HMG‐CoA reductase inhibition protects the diabetic myocardium from ischemia‐reperfusion injury (2001) (117)
- Elevated ambient glucose induces acute inflammatory events in the microvasculature: effects of insulin. (2001) (113)
- Neutrophil-mediated vasoconstriction and endothelial dysfunction in low-flow perfusion-reperfused cat coronary artery. (1991) (113)
- Nitric oxide: nature's naturally occurring leukocyte inhibitor. (1997) (111)
- Leukotrienes as mediators of ischemia and shock. (1986) (109)
- Regulation of P-selectin expression in human endothelial cells by nitric oxide. (1997) (104)
- Cardioprotective effects of acidified sodium nitrite in myocardial ischemia with reperfusion. (1990) (104)
- Mechanisms of amelioration of glucose-induced endothelial dysfunction following inhibition of protein kinase C in vivo. (2002) (102)
- Peroxynitrite reduces myocardial infarct size and preserves coronary endothelium after ischemia and reperfusion in cats. (1997) (101)
- Synthesis and biological properties of pinane-thromboxane A2, a selective inhibitor of coronary artery constriction, platelet aggregation, and thromboxane formation. (1979) (101)
- Inhibition of nitric oxide biosynthesis promotes P-selectin expression in platelets. Role of protein kinase C. (1995) (99)
- Role of P-selectin in microvascular leukocyte-endothelial interaction in splanchnic ischemia-reperfusion. (1994) (99)
- Cardioprotective effects of a novel proteasome inhibitor following ischemia and reperfusion in the isolated perfused rat heart. (1999) (97)
- Protective actions of naloxone in hemorrhagic shock. (1980) (97)
- Mechanisms of cardioprotection by peroxynitrite in myocardial ischemia and reperfusion injury. (1998) (95)
- Attenuation of myocardial ischemia-reperfusion injury with nitric oxide replacement therapy. (1995) (95)
- Role of platelet-activating factor-acether in mediating guinea pig anaphylaxis. (1986) (94)
- Beneficial effects of two forms of NO administration in feline splanchnic artery occlusion shock. (1990) (93)
- Essential Role of P-Selectin in the Initiation of the Inflammatory Response Induced by Hemorrhage and Reinfusion (1999) (92)
- Mechanisms of vascular preservation by a novel NO donor following rat carotid artery intimal injury. (1995) (92)
- Preservation of ischemic myocardium by a new converting enzyme inhibitor, enalaprilic acid, in acute myocardial infarction. (1985) (91)
- Role of platelet activating factor in propagation of cardiac damage during myocardial ischemia. (1988) (88)
- Desmopressin induces endothelial P-selectin expression and leukocyte rolling in postcapillary venules. (1995) (88)
- Antishock and endothelial protective actions of a NO donor in mesenteric ischemia and reperfusion. (1992) (87)
- Direct measurement of nitric oxide release from vascular endothelial cells. (1996) (86)
- Characterization of a myocardial depressant factor present in hemorrhagic shock. (1967) (85)
- Beneficial effects of SPM-5185, a cysteine-containing NO donor in myocardial ischemia-reperfusion. (1992) (81)
- Studies on the mechanism of leukotriene induced coronary artery constriction. (1983) (81)
- Activated neutrophils aggravate endothelial dysfunction after reperfusion of the ischemic feline myocardium. (1992) (80)
- Beneficial effect of SPM-5185, a cysteine-containing nitric oxide donor, in rat carotid artery intimal injury. (1994) (80)
- Presence of a myocardial depressant factor in patients in circulatory shock. (1971) (78)
- Protection from myocardial reperfusion injury by acute administration of 17 beta-estradiol. (1996) (78)
- Brief Reviews: Blood‐Borne Humoral Factors in the Pathophysiology of Circulatory Shock (1973) (77)
- Significance of lipid mediators in shock states. (1989) (76)
- Thromboxane A2, prostacyclin and aspirin: effects on vascular tone and platelet aggregation. (1980) (75)
- Influence of thromboxane inhibition on the severity of myocardial ischemia in cats. (1980) (75)
- II. Nitric oxide protects in intestinal inflammation. (1999) (74)
- Actions of prostaglandins on isolated perfused cat coronary arteries. (1978) (71)
- Antibodies which antagonise the effects of prostacyclin (1978) (70)
- Cytokines and growth factors in endothelial dysfunction (1993) (68)
- Prostaglandin‐Induced Preservation of the Ischemic Myocardium (1978) (68)
- Cardioprotective effects of selective inhibition of the two complement activation pathways in myocardial ischemia and reperfusion injury. (1995) (67)
- Rosuvastatin, a New HMG-CoA Reductase Inhibitor, Protects Ischemic Reperfused Myocardium in Normocholesterolemic Rats (2003) (67)
- Homocysteine provokes leukocyte-endothelium interaction by downregulation of nitric oxide. (1999) (66)
- Salutary effects of prostacyclin in endotoxic shock. (1980) (65)
- Endothelial dysfunction and neutrophil adherence as critical events in the development of reperfusion injury. (1993) (64)
- Cardioprotective effect of interleukin-10 in murine myocardial ischemia-reperfusion. (1997) (63)
- Pancreatic hydrolases and the formation of a myocardial depressant factor in shock. (1972) (63)
- Thromboxane A2 in acute myocardial infarction. (1984) (62)
- Polymorphonuclear leukocyte-induced vasocontraction and endothelial dysfunction. Role of selectins. (1994) (61)
- Interaction between myocardial depressant factor and vasoactive mediators with ischemia and shock. (1987) (60)
- Potent constriction of cat coronary arteries by hydroperoxides of arachidonic acid and its blockade by anti-inflammatory agents. (1979) (59)
- Mechanisms of production of circulatory shock factors in isolated perfused pancreas. (1972) (58)
- A pharmacological approach to thromboxane receptor antagonism. (1987) (58)
- Caveolin-1 peptide exerts cardioprotective effects in myocardial ischemia-reperfusion via nitric oxide mechanism. (2001) (57)
- Cardioprotection by liposome-conjugated sialyl Lewisx-oligosaccharide in myocardial ischaemia and reperfusion injury. (1995) (57)
- Nitric oxide. II. Nitric oxide protects in intestinal inflammation. (1999) (55)
- C-peptide exerts cardioprotective effects in myocardial ischemia-reperfusion. (2000) (54)
- Cardioprotection by a novel recombinant serine protease inhibitor in myocardial ischemia and reperfusion injury. (1995) (54)
- Role of selectins in myocardial ischemia-reperfusion injury. (1995) (54)
- Pathophysiological mechanisms of sudden death induced by platelet activating factor (1984) (54)
- Influence of nonsteroidal anti-inflammatory agents on myocardial ischemia in the cat. (1976) (54)
- Cardiac venous endothelial dysfunction after myocardial ischemia and reperfusion in dogs. (1992) (54)
- Beneficial effects of ibuprofen in acute myocardial ischemia. (1979) (53)
- Cardioprotective effects of enalapril in acute myocardial ischemia. (1984) (53)
- Beneficial effects of a new potent and specific thromboxane receptor antagonist (SQ-29,548) in vitro and in vivo. (1985) (52)
- Use of hypertonic saline in the treatment of hemorrhagic shock. (1987) (52)
- Lipoxins A4 and B4: comparison of icosanoids having bronchoconstrictor and vasodilator actions but lacking platelet aggregatory activity. (1988) (51)
- Relationship between splanchnic blood flow and a myocardial depressant factor in endotoxin shock. (1971) (49)
- Endothelium and myocardial protecting actions of taprostene, a stable prostacyclin analogue, after acute myocardial ischemia and reperfusion in cats. (1990) (49)
- Humanized monoclonal antibody DREG-200 directed against I-selectin protects in feline myocardial reperfusion injury. (1994) (49)
- Inotropic influence of endogenous peptides in experimental hemorrhagic pancreatitis. (1971) (49)
- Mechanism of the protective effects of prostaglandins E1 and F2α in canine endotoxin shock (1973) (48)
- Pancreatic Hypoperfusion and the Production of a Myocardial Depressant Factor in Hemorrhagic Shock (1974) (47)
- Anti-ischemic actions of a new thromboxane receptor antagonist during acute myocardial ischemia in cats. (1985) (46)
- In vivo regulation of PECAM‐1 activity during acute endothelial dysfunction in the rat mesenteric microvasculature (1998) (46)
- Plasma activation during splanchnic arterial occlusion shock. (2000) (46)
- Time course of endothelial-neutrophil interaction in splanchnic artery ischemia-reperfusion. (1998) (46)
- Rapid restoration of normal endothelial functions in genetically hyperlipidemic mice by a synthetic mediator of reverse lipid transport. (2000) (45)
- Beneficial effects of a new thromboxane synthetase inhibitor in arachidonate-induced sudden death. (1981) (45)
- PR-39, a proline/arginine-rich antimicrobial peptide, exerts cardioprotective effects in myocardial ischemia-reperfusion. (2001) (44)
- Endothelial dysfunction in myocardial ischemia and reperfusion: role of oxygen-derived free radicals. (1991) (42)
- Mechanism of the protective effect of corticosteriods in hemorrhagic shock. (1969) (42)
- Vascular effects of poly-N-acetylglucosamine in isolated rat aortic rings. (2002) (41)
- Pulmonary artery endothelial dysfunction following ischemia and reperfusion of the rabbit lung. (1993) (41)
- Mechanism of coronary vasoconstriction induced by carbocyclic thromboxane A2. (1981) (41)
- Isolated cardiac myocytes are sensitized by hypoxia-reoxygenation to neutrophil-released mediators. (1994) (40)
- Mechanisms of the protective effects of transforming growth factor-beta in reperfusion injury. (1991) (40)
- Preservation of ischemic myocardium by pinane thromboxane A2. (1980) (40)
- Cardiac Performance in Experimental Adrenal Insufficiency in Cats (1968) (40)
- Cardioprotective and endothelial protective effects of [Ala‐IL8]77 in a rabbit model of myocardial ischaemia and reperfusion (1991) (39)
- Protective actions of a leukotriene B4 antagonist in splanchnic ischemia and reperfusion in rats. (1991) (39)
- Time course of endothelial dysfunction and myocardial injury during coronary arterial occlusion. (1991) (39)
- Effects of dexamethasone on myocardial cells in the early phase of acute myocardial infarction. (1975) (39)
- Properties of cardioinhibitory factors produced in shock. (1978) (38)
- Anti-ischemic actions of a new thromboxane receptor antagonist, SQ-29,548, in acute myocardial ischemia. (1986) (38)
- Production of a myocardial depressant factor in cardiogenic shock. (1971) (37)
- Circulatory Responses to Splanchnic Lysosomal Hydrolases in the Dog (1972) (37)
- Role of the β2-integrins and immunoglobulin superfamily members in myocardial ischemia-reperfusion (1999) (36)
- Protective effect of thoracic lymph diversion in hemorrhagic shock. (1970) (36)
- Prevention of extension of ischaemic damage following acute myocardial ischaemia by dazoxiben, a new thromboxane synthetase inhibitor. (1983) (36)
- Beneficial actions of a free radical scavenger in traumatic shock and myocardial ischemia. (1981) (35)
- Eicosanoids as mediators of ischemia and shock. (1985) (35)
- Anti-toxic action of methylprednisolone in hemorrhagic shock. (1971) (35)
- Anti-ischaemic and endothelial protective actions of recombinant human osteogenic protein (hOP-1). (1992) (35)
- P‐selectin is up‐regulated in vital organs during murine traumatic shock (1997) (34)
- Role of the pancreas in the pathogenesis of circulatory shock. (1971) (34)
- Protection of Ischemic Cat Myocardium By CGS‐13080, a Selective Potent Thromboxane A2 Synthesis Inhibitor (1983) (34)
- Prostacyclin, high density lipoproteins, and myocardial ischemia. (1990) (34)
- Protective actions of a stable prostacyclin analog in ischemia induced membrane damage in rat myocardium. (1987) (34)
- Hypotensive Mechanisms of Amifostine (1996) (34)
- Wortmannin, a potent antineutrophil agent, exerts cardioprotective effects in myocardial ischemia/reperfusion. (2000) (34)
- Attenuation of neutrophil-mediated myocardial ischemia-reperfusion injury by a calpain inhibitor. (2002) (34)
- Mechanisms of the cardioprotective actions of WEB-2170, bepafant, a platelet activating factor antagonist, in myocardial ischemia and reperfusion. (1992) (33)
- Effects of peptide leukotrienes on cardiac dynamics in rat, cat, and guinea pig hearts. (1985) (33)
- Role of corticosteroids in the treatment of circulatory collapse states (1970) (33)
- Beneficial effects of tissue-type plasminogen activator in acute myocardial ischemia in cats. (1986) (33)
- Cardioprotective Actions of Specific Thromboxane Receptor Antagonist in Acute Myocardial Ischemia (1987) (33)
- Endotoxin, Cytokines, and Nitric Oxide in Shock: An Editiorial Comment (1994) (32)
- Altered Coronary Vascular Responsiveness to Leukotrienes In Alloxan‐Diabetic Rats (1984) (31)
- S-nitrosylated tissue-type plasminogen activator protects against myocardial ischemia/reperfusion injury in cats: role of the endothelium. (1996) (31)
- Endothelial dysfunction in the splanchnic circulation following ischemia and reperfusion (1991) (31)
- Synergism between superoxide dismutase and sodium nitrite in cardioprotection following ischemia and reperfusion. (1990) (31)
- Tissue factor expression in vital organs during murine traumatic shock: role of transcription factors AP-1 and NF-kappaB. (1999) (30)
- Beneficial actions of prostacyclin in traumatic shock. (1979) (30)
- Therapeutic role of nitric oxide donors in the treatment of cardiovascular disease (1994) (30)
- Protective actions of S-nitroso-N-acetylpenicillamine (SNAP) in a rat model of hemorrhagic shock. (1992) (30)
- Corticosteroid antagonism of the positive inotropic effect of ouabain. (1966) (30)
- Effect of recombinant soluble P-selectin glycoprotein ligand-1 on leukocyte-endothelium interaction in vivo. Role in rat traumatic shock. (1999) (29)
- Anti-Shock Effects of Human Superoxide Dismutase in Splanchnic Artery Occlusion (SAO) Shock (1988) (29)
- Effects of defibrotide on leukocyte-endothelial cell interaction in the rat mesenteric vascular bed: role of P-selectin. (1996) (29)
- Possible mechanisms of the beneficial action of glucocorticoids in circulatory shock. (1973) (29)
- Acute mesenteric ischemia and reperfusion: protective effects of recombinant soluble P-selectin glycoprotein ligand-1. (1999) (28)
- Proteolysis in formation of a myocardial depressant factor during shock. (1973) (28)
- Direct cardiovascular actions of two metabolites of linoleic acid. (1990) (28)
- Detection by chemical methods of a myocardial depressant factor in plasma of animals in circulatory shock. (1973) (28)
- Pancreatic perfusion in the pathophysiology of hemorrhagic shock. (1974) (28)
- Mechanism of antagonism of thromboxane receptors in vascular smooth muscle. (1987) (27)
- Induction of tissue injury and altered cardiovascular performance by platelet-activating factor: relevance to multiple systems organ failure. (1989) (27)
- Splanchnic vascular endothelial dysfunction in rat endotoxemia: role of superoxide radicals. (1992) (27)
- Effects of Calcium Channel Blockers on Arachidonate-Induced Sudden Death in Rabbits 1 (1981) (26)
- Advances in shock research (1979) (26)
- Role of thromboxanes and prostaglandin endoperoxides in the pathogenesis of eicosanoid induced sudden death. (1983) (26)
- Mechanisms of cardiodepression in endotoxin shock. (1979) (26)
- Localization of Glucocorticoid Uptake in Normal and Ischemic Myocardial Tissue of Isolated Perfused Cat Hearts (1976) (26)
- Cardioprotective effects of citrulline in ischemia/reperfusion injury via a non-nitric oxide-mediated mechanism. (2000) (25)
- The role of lysosomes in circulatory shock. (1976) (25)
- Beneficial actions of imidazole in endotoxin shock. (1980) (25)
- Autocrine effects of endothelin-1 on leukocyte-endothelial interaction: stimulation of endothelin B receptor subtype reduces endothelial adhesiveness via a nitric oxide-dependent mechanism. (1996) (25)
- Protection of endothelial damage and systemic shock by benidipine, a calcium antagonist, in rats subjected to splanchnic ischemia and reperfusion. (1991) (24)
- S-Nitroso-N-acetylpenicillamine is a Potent Inhibitor of Neutrophil-Endothelial Interaction (1993) (24)
- Myocardial and endothelial protection by TMS in ischemia-reperfusion injury. (1995) (24)
- Mechanisms of cardioprotection by peroxynitrite in myocardial ischemia and reperfusion injury. (1998) (23)
- Lysophosphatidylcholine stimulates leukocyte rolling and adherence in rat mesenteric microvasculature. (1997) (23)
- CARDIOVASCULAR EFFECTS OF CATECHOLAMINES IN EXPERIMENTAL ADRENAL INSUFFICIENCY. (1964) (23)
- Cardioprotective effects of abciximab (ReoPro) in an isolated perfused rat heart model of ischemia and reperfusion. (1999) (23)
- Thromboxane induced red blood cell lysis. (1987) (23)
- Cardioprotective actions of thromboxane receptor antagonism in ischemic atherosclerotic rabbits. (1988) (23)
- Salutary consequences of blockade of platelet activating factor in hemorrhagic shock. (1988) (23)
- Beneficial action of a new opiate antagonist (Win 44,441-3) in hemorrhagic shock. (1982) (22)
- Protective effects of a novel 21-aminosteroid during splanchnic artery occlusion shock. (1990) (22)
- Studies on the mechanism of the vasodilator action of nicorandil. (1988) (22)
- Protective action of timolol in acute myocardial ischemia. (1977) (22)
- Protective effects of a novel thromboxane analog in lethal traumatic shock. (1979) (21)
- PMN adherence to cat ischemic-reperfused mesenteric vascular endothelium under flow: role of P-selectin. (1994) (21)
- Isolation of myocardial depressant factor from plasma of dogs in hemorrhagic shock. (1977) (21)
- Leukocyte-dependent and leukocyte-independent mechanisms of impairment of endothelium-mediated vasodilation. (1990) (21)
- Arachidonic acid in splanchnic artery occlusion shock. (1976) (21)
- Protective effect of the specific thromboxane receptor antagonist, BM-13505, in reperfusion injury following acute myocardial ischemia in cats. (1989) (20)
- Influence of hemodialysis on a myocardial depressant factor in hemorrhagic shock. (1970) (20)
- Protective effects of a specific platelet activating factor (PAF) antagonist, WEB 2086, in traumatic shock. (1989) (20)
- Pharmacologic modulation of ATP release from isolated rat hearts in response to vasoconstrictor stimuli using a continuous flow technique. (1987) (20)
- Detection of platelet-activating factor during traumatic shock. (1988) (20)
- Cardioprotective actions of transforming growth factor-β. (1993) (20)
- Beneficial Action of a New Angiotensin‐ Converting Enzyme Inhibitor (SQ 14,225) in Hemorrhagic Shock in Cats (1978) (20)
- Sialyl Lewisx-containing oligosaccharide exerts beneficial effects in murine traumatic shock. (1994) (19)
- Endothelial alterations in hypercholesterolaemia and atherosclerosis. (1991) (19)
- Comparison of the effects of two factors present in plasma of shocked animals. (1968) (19)
- Thromboxane Is Produced in Response to Intracoronary Infusions of Complement C5a in Pigs Cyclooxygenase Blockade Does Not Reduce the Myocardial Ischemia and Leukocyte Accumulation (1989) (19)
- Vascular responsiveness and eicosanoid production in diabetic rats (1983) (19)
- Mechanism of protection against arachidonate induced sudden death by glucocorticoid. (1981) (19)
- Protective effect of pancreatic duct ligation in splanchnic ischemia shock. (1972) (19)
- Cardioprotective actions of human superoxide dismutase in two reperfusion models of myocardial ischaemia in the rat (1988) (18)
- Inhibition of the platelet activating factor mediated component of guinea pig anaphylaxis by receptor antagonists. (1986) (18)
- Early prostaglandin release from the ischemic myocardium in the dog. (1977) (17)
- Salutary effects of cysteine on cardiogenic shock in cats. (1978) (17)
- Antagonism of platelet aggregation by 13-azaprostanoic acid in acute myocardial ischemia and sudden death. (1983) (17)
- Platelets: unindicted coconspirators in inflammatory tissue injury. (2000) (17)
- Actions of opiate antagonists with selective receptor interactions in hemorrhagic shock. (1983) (17)
- Mechanisms of the optimal protective effects of ibuprofen in acute myocardial ischemia. (1980) (17)
- Salutary effects of nitrendipine, a new calcium entry blocker, in hemorrhagic shock. (1984) (17)
- Inhibitors of lipoxygenase products improve survival in traumatic shock. (1984) (17)
- Cardiac Actions of a Myocardial Depressant Factor Isolated from Shock Plasma 1 (1971) (17)
- Heterogeneity of vascular smooth muscle responsiveness to lipid vasoactive mediators. (1987) (17)
- Stabilization of cardiac lysosomal and cellular membranes in protection of ischemic myocardium due to coronary occlusion:efficacy of the nonsteroidal anti-inflammatory agent, naproxen. (1981) (17)
- Time course of endothelial-neutrophil interaction in splanchnic artery ischemia-reperfusion. (1998) (16)
- Release of prostaglandin F2alpha during splanchnic artery occlusion shock. (1976) (16)
- Antiaggregatory effects of thromboxane receptor antagonists in vivo. (1985) (16)
- Anti-shock effects of human superoxide dismutase in splanchnic artery occlusion (SAO) shock. (1988) (16)
- Endothelin-1, endothelin receptors and ecNOS gene transcription in vital organs during traumatic shock in rats. (1999) (16)
- Effects of a metalloproteinase that truncates P-selectin glycoprotein ligand on neutrophil-induced cardiac dysfunction in ischemia/reperfusion. (1998) (16)
- Ischemia aggravating effects of platelet-activating factor in acute myocardial ischemia (1985) (16)
- Beneficial actions of thromboxane receptor antagonism in hemorrhagic shock. (1986) (15)
- The pathophysiologic role of myocardial depressant factor as a mediator of circulatory shock (1982) (15)
- Endothelial preserving actions of a nitric oxide donor in carotid arterial intimal injury. (1994) (15)
- Beneficial actions of CP-0127, a novel bradykinin receptor antagonist, in murine traumatic shock. (1994) (15)
- Absence of a cardiodynamic action of glucocorticoids in acute myocardial ischemia. (1976) (15)
- Inotropic and vasoactive effects of the naturally occurring angiotensins in isolated cat cardiac muscle and coronary arteries. (1979) (15)
- Shock- and ischemia-induced mechanisms of impairment of endothelium-mediated vasodilation. (1991) (15)
- Constriction of cat coronary arteries by synthetic thromboxane A2 and its antagonism. (1987) (14)
- Beneficial effects of N,N,N-trimethylsphingosine following ischemia and reperfusion in the isolated perfused rat heart. (1998) (14)
- Protective action of a thromboxane synthetase inhibitor in preventing extension of infarct size in acute myocardial infarction. (1985) (14)
- Role of AVP in maintenance of circulatory homeostasis during hemorrhagic shock. (1984) (14)
- Protein kinase inhibition exerts cardioprotective effects in myocardial ischemia/reperfusion via inhibition of superoxide release. (2001) (14)
- Pulmonary tissue factor mRNA expression during murine traumatic shock: effect of P-selectin blockade. (2001) (14)
- Coronary Vascular Actions of Synthetic Atrial Natriuretic Factor in Isolated Vascular Preparations (1987) (14)
- Protective actions of propyl gallate, a lipoxygenase inhibitor, on the ischemic myocardium. (1985) (14)
- Beneficial actions of antagonism of peptide leukotrienes in hemorrhagic shock. (1988) (13)
- Use of a novel peptide leukotriene receptor antagonist, Ly-163443, in splanchnic artery occlusion shock. (1988) (13)
- Effects of prostaglandins on distribution of blood flow in the cat. (1978) (13)
- Administration of polymerized bovine hemoglobin improves survival in a rat model of traumatic shock. (1999) (13)
- Mechanism of the lack of a beneficial response to inotropic drugs in hemorrhagic shock (1971) (13)
- Effect of glucocorticoid on prostaglandin production during simulated shock conditions in the perfused cat liver. (1977) (13)
- CARDIOVASCULAR ACTIONS OF TWO THROMBOXANE A2 ANALOGS (1981) (12)
- Beneficial Effects of Arachidonic Acid during Hemorrhagic Shock in the Dog (1977) (12)
- Salutary actions of nimodipine in traumatic shock. (1981) (12)
- Endotoxin, cytokines, and nitric oxide in shock. (1994) (12)
- Synthesis and biological properties of 12-fluoroprostacyclins (1978) (12)
- Influence of mineralocorticoids and cations on the inotropic effect of angiotensin and norepinephrine in isolated cardiac muscle. (1967) (12)
- Cardioprotective actions of a selective thromboxane synthetase inhibitor in acute myocardial ischemia. (1983) (12)
- Beneficial actions of two novel calcium entry blockers in the isolated perfused hypoxic cat liver. (1985) (12)
- Novel recombinant serpin, LEX-032, attenuates myocardial reperfusion injury in cats. (1996) (12)
- Nitric Oxide in Inflammation (2001) (12)
- Inhibition of Leukotriene Actions by the Calcium Channel Blocker, Nisoldipine 1 (1986) (11)
- Analysis of potential beneficial actions of prostaglandins in traumatic shock. (1983) (11)
- Pharmacologic profile of lipoxins A5 and B5: new biologically active eicosanoids. (1989) (11)
- A comparison of vascular biological actions of carbon monoxide and nitric oxide (1993) (11)
- Delayed appearance of a circulating myocardial depressant factor in burn patients. (1981) (11)
- Anti-aggregatory actions of calcium channel blockers in cat platelets. (1982) (10)
- Influence of increased circulating levels of splanchnic lysosomal enzymes on the response to myocardial ischemia. (1975) (10)
- Significance of production of peptide leukotrienes in murine traumatic shock. (1986) (10)
- Specificity of anti-leukotriene actions of nicardipine. (1984) (10)
- Mechanism of the beneficial effect of dexamethasone on myocardial cell integrity in acute myocardial ischemia (1980) (10)
- Anti-shock properties of the prostacyclin analog, iloprost, in traumatic shock. (1986) (10)
- Further characterization of a myocardial depressant factor present in hemorrhagic shock. (1969) (10)
- Mechanism of the pressor effect of the calcium agonist, BAY k 8644, in the intact rat. (1986) (10)
- Protective effects of a new LTD4 antagonist (LY-171883) in traumatic shock. (1985) (10)
- Potentiation of the protective effects of a converting enzyme inhibitor and a thromboxane synthetase inhibitor in hemorrhagic shock. (1987) (10)
- Comparative pharmacology of nitric oxide and nitric oxide generators on cardiac contractility in mammalian species. (1995) (10)
- Role of the beta2-integrins and immunoglobulin superfamily members in myocardial ischemia-reperfusion. (1999) (9)
- Efficacy of a combination thromboxane receptor antagonist and lipoxygenase inhibitor in traumatic shock. (1988) (9)
- Differentiation of a Myocardial Depressant Factor Present in Shock Plasma from Known Plasma Peptides and Salts 1 (1973) (9)
- Novel beneficial effects of defibrotide, an endothelium protecting agent, following ischemia and reperfusion in the isolated perfused rat heart. (1998) (9)
- Circulatory and platelet actions of 6,9-thiaprostacyclin (PGI2-S) in the cat. (1979) (9)
- Heparinase III exerts endothelial and cardioprotective effects in feline myocardial ischemia-reperfusion injury. (1997) (9)
- Thromboxane A2 in acute myocardial infarction (1982) (9)
- Production of a myocardial depressant factor in shock following acute myocardial infarction: Preliminary evaluation of treatment with methylprednisolone☆ (1972) (9)
- Leukotriene production in isolated tissues of diabetic rats. (1984) (9)
- Cardiac effects of oxyfedrine in the cat. (1970) (9)
- Tissue Factor Expression in Vital Organs during Murine Traumatic Shock Role of Transcription Factors AP-1 and NF-κB (1999) (9)
- Nitric Oxide Donors in Endotoxic and Septic Shock: Evidence Against Nitric Oxide as a Mediator of Shock (1998) (9)
- Hyperreactivity of coronary vasculature in platelet-perfused hearts from diabetic rats. (1983) (9)
- Novel beneficial mechanisms of defibrotide, a prostacyclin enhancing agent in splanchnic artery occlusion and reperfusion in rats. (1991) (9)
- Lysosomal hypothesis in evolution of myocardial infarction. Subcellular fractionation and electron microscopic cytochemical study. (1979) (9)
- Protective effects of KW-3635, a novel thromboxane A2 antagonist, in murine traumatic shock. (1990) (9)
- Preservation of ischemic myocardial tissue with an antagonist of vasoconstrictor eicosanoids. (1984) (9)
- Modulation of leukotriene synthesis and actions by synthetic derivatives of arachidonic acid. (1985) (8)
- Alterations in cardiac lymph dynamics in acute myocardial ischemia in dogs. (1977) (8)
- Protective effects of CG-4203, a novel stable prostacyclin analog, in traumatic shock. (1988) (8)
- Coronary endothelium-protective effects of defibrotide in ischaemia and reperfusion (1990) (8)
- Protective actions of ibuprofen in arachidonate-induced sudden death. (1983) (8)
- Anti-shock actions of a new converting enzyme inhibitor, enalaprilic acid, in hemorrhagic shock in cats. (1984) (8)
- Beneficial actions of a new thromboxane analog in traumatic shock. (1980) (8)
- Influence of verapamil on cellular integrity and electrolyte concentrations of ischemic myocardial tissue in the cat (1979) (8)
- Protective actions of a new thromboxane synthetase inhibitor in arachidonate induced sudden death. (1984) (8)
- Vasoactive effects of eicosapentaenoic acid on isolated vascular smooth muscle (1987) (8)
- Influence of humoral shock factors on in vitro aggregation of dog platelets. (1976) (8)
- Factors Influencing Nonspecific Binding of Glucocorticoids in Myocardial Tissue 1 (1976) (8)
- Lack of effect of thyrotropin releasing hormone (TRH) in circulatory shock (1985) (8)
- Vascular responsiveness of the in situ perfused dog pancreas. (1974) (8)
- Cardioprotective actions of a new calcium channel blocker in acute myocardial ischemia. (1986) (8)
- Antagonism of thromboxane actions in the isolated perfused rat heart. (1986) (8)
- Beneficial mechanisms of action of a prostacyclin enhancing agent in splanchnic artery occlusion shock. (1988) (8)
- Effects of taprostene on neutrophil-endothelial interactions in isolated coronary arteries. (1994) (8)
- Cardioprotective actions of nisoldipine in postreperfusion myocardial ischemia. (1988) (8)
- Protective action of a protease inhibitor in hemorrhagic shock. (1973) (8)
- Factors influencing the in vitro production of a myocardial depressant factor. (1973) (8)
- Infarct size restriction in cats by the β-adrenergic blocker timolol (1982) (7)
- Dissociation of vasoconstrictor and platelet aggregatory activities of thromboxane by carbocyclic thromboxane A 2 , a stable analog of thromboxane A 2 ( coronary arteries / thromboxane synthetase / platelet aggregation / sudden death ) (7)
- Anti-endotoxin actions of methylprednisolone in the isolated perfused cat liver. (1978) (7)
- Beneficial actions of the thromboxane receptor antagonist, AH-23,848, in acute myocardial ischemia. (1987) (7)
- Endothelial Dysfunction as an Early Critical Event in Ischemia and Shock (1993) (7)
- Beneficial effect of anisodamine in hemorrhagic shock (1984) (7)
- Protective action of prostaglandin E1 (PGE1) against constrictor mediators in isolated rat heart and lung. (1988) (7)
- Thromboxane A2 in health and disease. (1987) (7)
- Prostaglandin metabolism during circulatory shock. (1977) (7)
- Protective actions of dexamethasone in acute cerebral ischemia. (1982) (7)
- Influence of dopamine on liver dynamics in hemorrhagic shock. (1977) (7)
- Mechanisms of inhibition of nitric oxide production in a murine model of splanchnic artery occlusion shock. (1991) (7)
- Antagonism of Thromboxane Analog‐Induced Vasoconstriction by Non‐Steroidal Anti‐inflammatory Agents (1981) (7)
- Phenylephrine derivatives as leukotriene D4 antagonists. (1987) (7)
- Shock potentiating actions of angiotensin II infusion in cats. (1980) (7)
- Myocardial depressant factor and circulatory shock (1974) (6)
- Role of Eicosanoids in Circulatory Shock (1985) (6)
- Beneficial effects of ibuprofen in pacing-induced myocardial ischemia. (1983) (6)
- Preservation of myocardial integrity by a protease inhibitor during acute myocardial ischemia. (1974) (6)
- Mechanism of the Protective Effect of Angiotensin-Converting Enzyme Inhibition in Hemorrhagic Shock 1 (1979) (6)
- Role of the prostaglandin-thromboxane system in vascular homeostasis during shock. (1979) (6)
- Cardioprotective actions of the specific thromboxane receptor antagonist (+)-S145Na following coronary occlusion and reperfusion in the rat. (1990) (6)
- Pharmacological actions of synthetic atrial natriuretic factor on coronary vascular smooth muscle. (1988) (6)
- Factors Influencing the Inotropic Effect of Corticosteroids.∗ (1967) (6)
- Mechanisms of action of PGE1 in hemorrhagic shock in rats. (1988) (6)
- Commentaries on this month's Controversy articles (1993) (6)
- Preservation of cardiac cellular integrity by methylpred-nisolone in acute myocardial ischemia (1974) (6)
- Protective effects of a new specific thromboxane antagonist in arachidonate-induced sudden death. (1987) (6)
- Tissue uptake of 3H-methylprednisolone in acute myocardial ischemia. (1977) (6)
- SQ-29548: A highly potent and specific thromboxane A2 receptor antagonist (1987) (6)
- L-arginine attenuates endothelial dysfunction and prolongs survival in rats subjected to traumatic shock. (1998) (6)
- Protective effects of the specific thromboxane receptor antagonist (+)-S145Na in splanchnic artery occlusion shock in rats. (1990) (6)
- The Role of Nitric Oxide in Ischemia-Reperfusion (2000) (6)
- The protective effects of nifedipine in the isolated cat heart. (1983) (6)
- Beneficial actions of RO 15-1788, a benzodiazepine receptor antagonist, in hemorrhagic shock. (1987) (5)
- Myocardial actions of prostaglandins in isolated cat cardiac tissue. (1975) (5)
- Modulation of circulatory responses to enkephalins by cyclooxygenase inhibitors. (1983) (5)
- Beneficial effects of a neutral protease inhibitor in traumatic shock. (1985) (5)
- Protective effect of nifedipine in the hypoxic perfused cat liver (1981) (5)
- Salutary effects of anisodamine in murine traumatic shock. (1983) (5)
- Thromboxane A2 and leukotrienes are eicosanoid mediators of shock and ischemic disorders. (1988) (5)
- Influence of Positive Inotropic Agents on the Action of a Myocardial Depressant Factor in the Plasma of Cats in Postoligemic Shock.∗ (1967) (5)
- Fourth International Shock Congress and Twenty-Second Annual Conference on Shock Philadelphia, Pennsylvania (1999) (5)
- Cellular mechanisms of heparinase III protection in rat traumatic shock. (1998) (5)
- The lysosomal protease--myocardial depressant factor system in circulatory shock. (1972) (5)
- Potentiation of coronary vascular platelet adhesion by atrial pacing in the presence of arterial stenosis in dogs. (1984) (5)
- Thromboxane synthetase inhibitors differentially antagonize thromboxane receptors in vascular smooth muscle (1981) (5)
- Functional characteristics and lysosomal integrity of the isolated perfused cat pancreas. (1971) (4)
- Role of Endothelium-Derived Relaxing Factor as a Cardioprotective Agent in Myocardial Ischemia (1990) (4)
- Influence of artificial respiration on cardiovascular performance after open-heart surgery. (1968) (4)
- Use of the novel cardiotonic and vasodilator agent pimobendan in traumatic shock. (1988) (4)
- Pinane thromboxane A2: a TXA2 antagonist with antithrombotic properties. (1980) (4)
- Mechanism of the protective effect of conditioning in rats subjected to Noble-Collip drum trauma. (1979) (4)
- Effect of angiotensin II receptor blockade by [Sar1-Ala8]angiotensin II in hemorrhagic shock. (1979) (4)
- Effects of LEX032, a novel recombinant serine protease inhibitor, on N(G)-nitro-L-arginine methyl ester induced leukocyte-endothelial cell interactions. (1998) (4)
- Actions of dopamine in splanchnic artery occlusion shock. (1978) (4)
- Salutary actions of thromboxane synthetase inhibition during global myocardial ischemia (1982) (4)
- Glucocorticoid protection of hepatic phagocytosis in hypoxia. (1979) (4)
- Modulation of receptor mediated leukotriene release in the perfused heart. (1986) (4)
- Role of the splanchnic visceral organs in development of tolerance to traumatic shock. (1980) (4)
- Preservation of hepatic cell integrity by aprotinin in hypoxia. (1977) (4)
- Hepatic blood flow in acute myocardial ischemia (1979) (4)
- Protective effects of a monoclonal antibody against lipid A in endotoxic shock. (1994) (4)
- Absence of direct inotropic effects of peptide leukotrienes in isolated mammalian heart preparations. (1985) (4)
- Influence of artificial respiration on cardiovascular performance after open-heart surgery (1967) (4)
- Peroxynitrite as a cytoprotective agent in myocardial ischemia/reperfusion injury (1998) (4)
- Protective actions of aprotinin in acute traumatic shock. (1979) (4)
- Beneficial actions of BN 50739, a new PAF receptor antagonist, in murine traumatic shock. (1990) (4)
- Tissue uptake of 3H-naloxone in control and in hemorrhagic shock cats. (1982) (4)
- Protective effects of thromboxane receptor blockade in splanchnic artery occlusion shock. (1988) (3)
- Effects of adenosine, an adenosine-A1 antagonist, and their combination in splanchnic occlusion shock in rats. (1992) (3)
- Myocardial uptake and metabolism of (3H)methylprednisolone in isolated cat hearts. (1977) (3)
- Vascular responsiveness of constant flow perfused arteries with intact endothelium. (1989) (3)
- Prevention of hypoxia-induced liver damage by three-day glucocorticoid administration. (1979) (3)
- Role of Thromboxane A2 in Coronary Vascular Disorders (1985) (3)
- Daltroban, a thromboxane receptor antagonist, protects the myocardium against reperfusion injury following myocardial ischemia without protecting the coronary endothelium. (1990) (3)
- Role of a myocardial depressant factor in shock states. (1973) (3)
- Cardiac effects of prostaglandins during global ischemia in isolated perfused cat hearts. (1982) (3)
- Protective action of 6-keto-prostaglandin E1 in traumatic shock. (1979) (3)
- Platelet activating factor (PAF) and its role in cardiac injury. (1989) (3)
- Pathophysiology and therapeutics of myocardial ischemia : proceedings of the A. N. Richards Symposium, Philadelphia, May 6-7, 1976 (1977) (3)
- Synthesis and vascular actions of an arachidonic acid ethylene-diamino-triethyl-ester (AA-EDTA) derivative. (1986) (3)
- Comparison of the cytotoxic actions of hypoxia and endotoxin in the perfused cat liver. (1978) (3)
- Dietary modification of the vascular effect of prostacyclin in hypertensive rats. (1980) (3)
- Coronary vasoactivity of four 7,13-bridged analogs of arachidonic acid. (1986) (3)
- Effects of lipoxygenase inhibitors in arachidonate‐induced sudden death † (1984) (3)
- Anti-thromboxane A2 actions of pinane thromboxane A2 derivatives. (1982) (3)
- Beneficial effects of a specific leukotriene receptor antagonist in splanchnic artery occlusion shock. (1989) (3)
- Mechanism of the protective action of Bay-u-3405, a new specific thromboxane receptor antagonist, in arachidonate-induced sudden death. (1991) (3)
- Phagocytosis and Bactericidal Activity of Leukocytes in Hemorrhagic Shock (1970) (3)
- Prostaglandin-mediated, angiotensin-induced vasoconstriction in isolated cat arteries. (1980) (3)
- Protection Against Cardiovascular Collapse in Acute Adrenalectomy by Autonomic Blocking Agents.∗ (1965) (3)
- Cardiac Effects of Peptidoleukotrienes (1985) (3)
- Oligotide attenuates leukocyte-endothelial cell interaction via P-selectin in the rat mesenteric vascular bed. (1996) (3)
- Introduction: Why Nitric Oxide Donors? (1993) (3)
- Effects of lisinopril, a new angiotensin converting enzyme inhibitor in a cryo-injury model of chronic left ventricular failure. (1986) (3)
- Endothelial Dysfunction as a Trigger for Ischemia-Reperfusion Injury (2004) (3)
- Protective effects of a combination thromboxane synthesis inhibitor-receptor antagonist, R-68070, during murine traumatic shock. (1989) (3)
- Mechanisms of the Hepatoprotective Effect of Nitrendipine in the Isolated Perfused Cat Liver (1987) (3)
- Beneficial action of naloxone in splanchnic artery occlusion shock (1981) (3)
- Cardiovascular Effects of Su-4885 (Mepyrapone), An Inhibitor of Corticosteroid Biosynthesis.∗ (1964) (3)
- Tissue Uptake and Distribution of 3H-Dexamethasone in Early Myocardial Ischemia1 (1976) (2)
- Physiologic and pathophysiologic role of cyclo-oxygenase metabolites of arachidonic acid in circulatory disease states. (1987) (2)
- Clearance of prostaglandin F2α during circulatory shock (1975) (2)
- Influence of atherosclerosis on vascular responsiveness in isolated rabbit vascular smooth muscle (1987) (2)
- Protection of hypoxic cytotoxicity by glucocorticoid in the liver (1976) (2)
- Selectins: vital vasculotropic vectors involved in vascular remodeling. (1997) (2)
- Nitric Oxide: A Critical Determinant in Ischemia-Reperfusion (2000) (2)
- Biphasic actions of chlorpromazine and mepacrine on modulation of hepatic cell injury in the perfused cat liver. (1981) (2)
- Effect of induced thrombocytopenia on experimental circulatory shock. (1976) (2)
- STARLING AND LOVATT EVANS PRINCIPLES OF HUMAN PHYSIOLOGY (1969) (2)
- Lack of a significant protective effect of augmented circulating glucose on the ischemic myocardium.BJ. (1976) (2)
- CGS-12970, a thromboxane synthetase inhibitor, limits ischemic damage following coronary artery occlusion. (1986) (2)
- Nitric oxide homeostasis control as therapy for cardiovascular diseases. (1993) (2)
- Plasma Prostaglandin F2α and 15-Keto-F2α Concentrations During Splanchnic Artery Occlusion Shock 1 (1976) (2)
- Role of thromboxane A2 in myocardial ischemia and circulatory shock. (1989) (2)
- Infarct size restriction in cats by the beta-adrenergic blocker timolol. (1982) (2)
- Increased severity of acute myocardial ischemia in experimental atheroscelerosis (2005) (2)
- VASODILATION RESULTING FROM MESENTERIC TRACTION IS MEDIATED BY PROSTACYCLIN (PGI2) (1987) (2)
- Continuous Measurements of ATP Secretion in Vivo (2004) (2)
- Nitric Oxide in Myocardial and Splanchnic Ischemia/ Reperfusion (1999) (2)
- Mechanisms of platelet-activating factor-induced cardiac depression in the isolated perfused rat heart. (1987) (2)
- Lack of thromboxane A2 involvement in the arrhythmias occurring during acute myocardial ischemia in dogs (1982) (2)
- Cellular Actions of Nitric Oxide on the Circulatory System (1995) (2)
- Physiologic mechanisms in acute myocardial infarction. (1975) (2)
- Protective actions of nafazatrom in traumatic shock. (1982) (2)
- Mechanisms of platelet activating factor induced cardiac anaphylaxis in the isolated perfused rat heart (1986) (2)
- Editorial comments: controversy over myocardial depressant factor in shock. (1973) (2)
- Platelet-activating factor (PAF) antagonistic actions of two new analogs of tetrahydrofurans. (1989) (2)
- Actions of non-cardiodepressant beta-adrenergic blocking agents in hemorrhagic shock. (1980) (1)
- Cellular mechanisms of heparinase III protection in rat traumatic shock. (1998) (1)
- In vivo anti-platelet properties of anipamil, a calcium channel blocker, in the rabbit. (1986) (1)
- Thromboxane A: Effects on Vascular Tone and Platelet Aggregation, Prostacyclin and Aspirin: Effects on Vascular Tone and Platelet Aggregation (1980) (1)
- Mechanisms of the anti-inflammatory action of rosuvastatin, a new HMG-CoA reductase inhibitor (2001) (1)
- Preservation of cellular integrity as a protective mechanism of dexamethasone in hemorrhagic shock in the cat. (1978) (1)
- The Microcirculation: Introduction to the Spotlight Issue (1996) (1)
- Anti-shock actions of the pyrimido-pyrimidine derivative, RA-642. (1986) (1)
- Peripheral effects of opiate antagonists in shock. (1983) (1)
- Lysosomal hypothesis in evolution of myocardial infarct (1979) (1)
- Direct positive inotropic and vasoconstrictor effects of endothelin (2005) (1)
- Role of transforming growth factor ß in cardioprotection of the ischemic-reperfused myocardium (1993) (1)
- Amelioration of splanchnic artery occlusion (SAO) shock by cysteine. (1978) (1)
- Effects of Hormones on the Heart (1980) (1)
- Influence of lysosomal enzymes on circulatory function. (1971) (1)
- Preservation of myocardial membrane integrity in the early phase of acute myocardial ischemia. (1976) (1)
- THE SHOCK SOCIETY OFFICERS OF THE SOCIETY 2014–2015 (2015) (1)
- Tissue uptake of isotopically labeled aprotinin in early myocardial ischemia. (1977) (1)
- Time Course of Glucocorticoid Dependent Changes in Cardiac Glycogen Concentration∗ (1969) (1)
- Effectiveness of ethylketocyclazocine in hemorrhagic shock. (1983) (1)
- Effects of prostacyclin and taprostene in splanchnic artery occlusion shock. (1991) (1)
- Protective actions of a new potent thromboxane receptor antagonist in arachidonate induced sudden death. (1989) (1)
- Actions of a protease inhibitor in arachidonate induced sudden death in rabbits. (1982) (1)
- Positive feedback actions of a myocardial depressant factor in circulatory shock. (1979) (1)
- Coronary vascular responsiveness to non-eicosanoid vasoconstrictors in the perfused diabetic rat heart. (1984) (1)
- Vasculoprotective Actions of Nitric Oxide (1995) (1)
- Thromboxanes and leukotrines in mycoardial infarction (1987) (0)
- Enteric administration of anisodamine in the treatment of hemorrhagic shock (2008) (0)
- Glucocorticoids in shock: lysosomal disruption, toxic factor formation and hepatic integrity (1977) (0)
- Leukotrienes in cardiovascular and pulmonary function (1985) (0)
- NITRIC OXIDE REGULATION OF NF-[Greek small letter kappa] B BINDING IN HUMAN ENDOTHELIAL CELLS (1998) (0)
- A NOVEL ANTI-APOPTOTIC AGENT (LXR-1035) INHIBITS LEUKOCYTE-ENDOTHELIUM INTERACTION IN VIVO (1999) (0)
- Leukotrienes in coronary angiopathy of diabetes. (1985) (0)
- Efficacy of two leukotriene antagonists in rat traumatic shock. (1987) (0)
- Pharmacologic and surgical modulation of myocardial depressant factor formation and action during shock. (1983) (0)
- New cardiovascular drugs 1987 Edited by Alexander Scriabine Raven Press, New York (1987) 271 pages, Illustrated, $69.00 ISBN: 0‐88167‐308‐0 (1988) (0)
- DEFICIENCY OR FUNCTIONAL INHIBITION OF P-SELECTIN ATTENUATES LEUKOCYTE-ENDOTHELIUM INTERACTION INDUCED BY HEMORRHAGE AND REINFUSION (1999) (0)
- Time Course of Intercellular Adhesion Molecule-1 Upregulation Following Endotoxin Administration (1998) (0)
- Prostaglandins in cardiovascular and renal function : proceedings of the 20th annual A.N. Richards Symposium of the Physiological Society of Philadelphia, King of Prussia, Pennsylvania, May 8-9, 1978 (1980) (0)
- Role of Leukotrienes in the Pathogenesis of Shock and Trauma (1987) (0)
- Mechanism of the protective effects of prostaglandins E1 and F2 alpha in canine endotoxin shock. (1973) (0)
- Beneficial effects of prostaglandin E1 infusion in experimental traumatic shock (1987) (0)
- A NOVEL ROLE FOR THE INDUCIBLE ISOFORM OF NITRIC OXIDE SYNTHASE (iNOS) ON THE ANTI‐INFLAMMATORY EFFECT OF STATINS.: 281 (2001) (0)
- Comment Prostacyclin , High Densit Lipoproteins , and Myocardial Ischemia (2005) (0)
- Effect of suppression of endocrine or exocrine pancreatic function in hemorrhagic shock (2005) (0)
- Cardioprotective Actions of Nisoldipine in Postreinfusion Myocardial Ischemia (1988) (0)
- (coronary arteries/thromboxane synthetase/platelet aggregation/s (2016) (0)
- [Endothelial damage and repair in myocardial ischemia and reperfusion]. (1993) (0)
- Anti-WC and Edothelialprotective Actions ofRecombinant Human Osteogenic Protein (hop-1) (1992) (0)
- Thromboxanes as mediators of cardiovascular disease states. (1985) (0)
- TOTAL SYNTHESIS OF 14-FLUOROPROSTAGLANDIN F2α AND 14-FLUOROPROSTACYCLIN (1979) (0)
- Rat Carotid Artery Intimal Injury (2005) (0)
- Preservation of ischemic myocardium by propyl gallate, a lipoxygenase inhibitor (1985) (0)
- POTENTIATION OF THE CARDIOVASCULAR EFFECTS OF NOREPINEPHRINE BY A TETRAHYDRO-BETA-CARBOLINE. (1964) (0)
- Lysosomal stabilizing effects of two non-steroidal anti-inflammatory agents in the hypoxic liver (1980) (0)
- ROLE OF INTEGRINS AND IMMUNOGLOBULIN FAMILY CELL ADHESION MOLECULES IN MYOCARDIAL ISCHEMIA/REPERFUSION: 189 (1997) (0)
- Acute Cardiovascular Effects of Adrenal Hormones in the Intact Dog (1962) (0)
- Effects of flurbiprofen on myocardial cell damage in acute myocardial ischemia. (1980) (0)
- TIME COURSE OF ENDOTHELIAL DYSFUNCTION AND LEUKOCYTE‐ENDOTHELIUM INTERACTION IN MURINE TRAUMATIC SHOCK.: 204 (1996) (0)
- Clearance of prostaglandin F2ALPHA during circulatory shock. (1975) (0)
- Beneficial effects of thromboxane receptor antagonists in acute cardiovascular crises. (1987) (0)
- LYOSOMES IN SHOCK 785 HOMOGENIZATION AND FRACTION ATION OF THE PANCREAS Preparation of Lysosomal Fraction (0)
- Comparison of surgical and humoral methods of induction of cardiogenic shock in cats. (1975) (0)
- -21-UPTAKE AND SUBCELLULAR LOCALIZATION OF GLUCOCORTICOIDS IN ISCHEMIC MYOCARDIUM : Cardiac Metabolism : PROCEEDINGS OF THE 42nd ANNUAL MEETING OF THE JAPANESE CIRCULATION SOCIETY (1978) (0)
- Contents, Vol. 61, 1976 (1976) (0)
- Acute effects of unsaturated fatty acids in splanchnic artery occlusion shock. (1989) (0)
- Pharmacologic antagonism of platelet activating factor and peptide leukotrienes inhibits guinea pig anaphylaxis. (1987) (0)
- Glucose and palmitate uptake in the myocardium of isolated hearts from adrenalectomized cats. (1976) (0)
- Salutary Effects of Two Verapamil Analogs in Traumatic Shock (1985) (0)
- A225 P-SELECTIN IS UPREGULATEDIN VITAL ORGANS DURING MURINE TRAUMATIC SHOCK (1997) (0)
- Subject Index, Vol. 61, 1976 (1976) (0)
- Role of leukotrienes (LT) in shock and trauma (1986) (0)
- LIPID ANALYSIS OF AORTIC TISSUE FROM ALLOXAN-DIABETIC RATS (1985) (0)
- Contents, Vol. 80, 1986 (1986) (0)
- Pharmacological modulation of myocardial depressant factor as a mediator of circulatory shock. (1989) (0)
- Role of leukotriene B4 in neutrophil-endothelium interactions. (1992) (0)
- BENEFICIAL EFFECTS OF A C1 ESTERASE INHIBITOR IN MURINE TRAUMATIC SHOCK.† 198 (1997) (0)
- Thromboxane A2, Prostacyclin and Aspirin: Effects (2005) (0)
- Prostacyclin, HighDensitLipoproteins, andMyocardial Ischemia (2013) (0)
- ANTI-SELECTIN THERAPY ATTENUATES NEUTROPHIL-MEDIATED ISCHEMIA-REPERFUSION INJURY TO THE VASCULAR ENDOTHELIUM AND DIMINISHES TISSUE DAMAGE (1995) (0)
- [Mechanisms that inhibit the formation and manifestation of the myocardial depressant factor in shock states]. (1980) (0)
- Metabolic and cardiac alterations in shock and trauma : papers presented at the first annual Conference on Shock, Airlie, Virginia, June 1978 (1979) (0)
- Molecular and cellular aspects of shock and trauma. Proceedings of the U.S.A.-Japan Binational Conference. Kona, Hawaii, June 21-24, 1982. (1983) (0)
- Reperfusion in Cats (2005) (0)
- Beneficial effect of a thromboxane synthetase inhibitor in traumatic shock. (1984) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Allan Mark Lefer?
Allan Mark Lefer is affiliated with the following schools:
